CAS: 1798328-24-1
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | TD52 REF: IN-DA01EQFNCAS: 1798328-24-1 | 98% | Prezzo su richiesta | Mar 15 Apr 25 |
 | TD52 REF: TM-T35528CAS: 1798328-24-1 | 99.5% | 67,00 €~96,00 € | Mar 22 Apr 25 |
 | N2,N3-Bis(3-ethynylphenyl)quinoxaline-2,3-diamine REF: 3D-YWC32824CAS: 1798328-24-1 | Min. 95% | 331,00 €~1.302,00 € | Mar 27 Mag 25 |
Ref: IN-DA01EQFN
| 5mg | 149,00 € | ||
| 50mg | 463,00 € | ||
| 100mg | 556,00 € | ||
| 250mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 15 Aprile 2025
TD52
CAS:1798328-24-1
TD52, an Erlotinib derivative, is an oral CIP2A cancer inhibitor that disrupts Elk1's attachment to …
Formula:
C24H16N4
Purezza:
99.5%
Colore e forma:
Liquid
Peso molecolare:
360.41
Ref: TM-T35528
| 2mg | 96,00 € |
Consegna stimata in Stati Uniti, il Martedì 22 Aprile 2025
N2,N3-Bis(3-ethynylphenyl)quinoxaline-2,3-diamine
CAS:1798328-24-1
Please enquire for more information about N2,N3-Bis(3-ethynylphenyl)quinoxaline-2,3-diamine including the price, delivery time and more detailed …
Formula:
C24H16N4
Purezza:
Min. 95%
Peso molecolare:
360.41 g/mol
Ref: 3D-YWC32824
| 5mg | 331,00 € | ||
| 10mg | 342,00 € | ||
| 25mg | 570,00 € | ||
| 50mg | 864,00 € | ||
| 100mg | 1.302,00 € |
Consegna stimata in Stati Uniti, il Martedì 27 Maggio 2025
